PHASE II STUDY OF INTERMITTENT ERLOTINIB (E) PLUS CARBOPLATIN (C), PACLITAXEL (P) AND BEVACIZUMAB (B) AS FRONTLINE TREATMENT OF PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC): AVAFAST STUDY

被引：0
|
作者：
Cobo Dols, Manuel A. [1 ]
Blanco, Esperanza [2 ]
Bernabe, Reyes [3 ]
Fernandez, Inmaculada [4 ]
Inoriza, Angel [5 ]
Laura Ortega, Ana [6 ]
Valdivia, Javier [7 ]
机构：
[1] Hru Carlos Haya, Malaga, Spain
[2] Hosp Infanta Cristina, Badajoz, Spain
[3] Hosp Nuestra Senora De Valme, Seville, Spain
[4] Hosp De Jerez, Cadiz, Spain
[5] Hosp Juan Ramon Jimenez, Huelva, Spain
[6] Complejo Hosp De Jaen, Jaen, Spain
[7] Hosp Univ Virgen Nieves, Granada, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
ADVANCED NSCLC; Intermittent Erlotinib; Clinical Trial in Progress;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.11-052
引用
收藏
页码：S1213 / S1213
页数：1
相关论文
共 50 条
  • [31] Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer
    Kaira, Kyoichi
    Tomizawa, Yoshio
    Yoshino, Reiko
    Miura, Yosuke
    Yoshii, Akihiro
    Iwasaki, Yasuki
    Koga, Yasuhiko
    Ono, Akihiro
    Hisada, Takeshi
    Minato, Koichi
    Sato, Koji
    Kazama, Toshifumi
    Ishihara, Shinichi
    Kohyama, Kenya
    Fueki, Naoto
    Saito, Ryusei
    Sunaga, Noriaki
    LUNG CANCER, 2013, 82 (01) : 103 - 108
  • [32] Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer
    Jones, Benjamin S.
    Jerome, Mary S.
    Miley, Deborah
    Jackson, Bradford E.
    DeShazo, Mollie R.
    Reddy, Vishnu V. B.
    Singh, Karan P.
    Brown, Olivia C.
    Robert, Francisco
    LUNG CANCER, 2017, 106 : 125 - 130
  • [33] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] A Phase II Study of Metformin with Pemetrexed/Carboplatin in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer
    Verma, S.
    Malik, P. S.
    Kalra, K.
    Singh, V.
    Kumar, S.
    Khurana, S.
    Pushpam, D.
    Jain, D.
    Gupta, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S130 - S131
  • [35] Bevacizumab plus Weekly Paclitaxel with or Without Carboplatin for Previously-treated Non-squamous Non-Small Cell Lung Cancer
    Hata, Akito
    Katakami, Nobuyuki
    Tanaka, Kosuke
    Takeshita, Jumpei
    Matsumoto, Takeshi
    Monden, Kazuya
    Nagata, Kazuma
    Masago, Katsuhiro
    Kaji, Reiko
    Fujita, Shiro
    Tachikawa, Ryo
    Otsuka, Kyoko
    Otsuka, Kojiro
    Tomii, Keisuke
    ANTICANCER RESEARCH, 2014, 34 (1A) : 275 - 281
  • [36] RANDOMIZED PHASE II STUDY OF PEMETREXED PLUS CARBOPLATIN FOLLOWED BY PEMETREXED VERSUS PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY PEMETREXED IN ADVANCED NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (LOGIK 0904)
    Shiraishi, Yoshimasa
    Inoue, Koji
    Takeshita, Masafumi
    Harada, Taishi
    Tashiro, Naoki
    Seto, Takashi
    Imanaga, Tomotoshi
    Fujimoto, Noriko
    Nakagaki, Noriaki
    Kawasaki, Masayuki
    Kishimoto, Junji
    Takayama, Koichi
    Ichinose, Yukito
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S403 - S404
  • [37] Phase II Study of Docetaxel-plus-Bevacizumab Combination Therapy in Patients Previously Treated for Advanced Non-squamous Non-small Cell Lung Cancer
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Kawano, Yuko
    Sakatani, Toshio
    Tanimoto, Azusa
    Nishizawa, Hironari
    Horiike, Atsushi
    Hagiwara, Sachiko
    Horai, Takeshi
    Nishio, Makoto
    ANTICANCER RESEARCH, 2014, 34 (09) : 5153 - 5158
  • [38] Phase I study of afatinib plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer harboring EGFR mutations
    Ko, Ryo
    Shukuya, Takehito
    Imamura, Chiyo K.
    Tokito, Takaaki
    Shimada, Naoko
    Koyama, Ryo
    Yamada, Kazuhiko
    Ishii, Hidenobu
    Azuma, Koichi
    Takahashi, Kazuhisa
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 183 - +
  • [39] Phase I/II study of atrasentan (A) in combination with carboplatin (C) and paclitaxel (P) in chemonaive patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Chiappori, A
    Haura, E
    Williams, C
    Simon, G
    Antonia, S
    Cantor, A
    Burton, MK
    Lush, R
    Sullivan, DM
    Bepler, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 646S - 646S
  • [40] Phase II study of carboplatin plus weekly paclitaxel with bevacizumab for non-squamous, non-small cell lung cancer with idiopathic interstitial pneumonia (Hanshin Cancer Group IP002)
    Katakami, Nobuyuki
    Nagata, Kazuma
    Nakakura, Akiyoshi
    Okamoto, Tadashi
    Kaneda, Toshihiko
    Oki, Masahide
    Watanabe, Kana
    Tokito, Takaaki
    Amano, Yoshihiro
    Tamiya, Motohiro
    Morita, Satoshi
    Hatachi, Yukimasa
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024,
12345